Zhejiang Pukang Biotechnology Co., Ltd is a state-level high-tech enterprise specializing in R&D, production and marketing. Pukang is the state’s first company which has obtained the approval number of Live Attenuated Hepatitis A Vaccine and independent intellectual property rights. And the EU pharmacopeia standard is implemented on the hepatitis A vaccine. It has acquired a broad recognition in the international market. Pukang has established a strong support system of vaccine research and its relevant basic subjects. In order to follow the development trend of biological pharmaceutical industry, Pukang, united with Zhejiang Academy of Medical Sciences, has built a provincial key laboratory of medical biological engineering vaccine, which greatly strengthened the supporting capacity and innovation ability of biological pharmaceuticals. In recent years, Pukang has undertaken the task of State 11th five-year supporting plan and several provincial crucial subjects, therefore has improved remarkably in scientific research. Pukang,adhering to the tenet of “Perfect our Quality, Promote the Innovation, Provide the Service, Protect your Health”, has been pursuing the innovation in technology, product and management so as to build itself as the world first-class vaccine production, research and development center.